A Prospective Case–control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in In vitro Fertilization-embryo Transfer Program

BACKGROUND: Recent developments in assisted reproductive technology focus on potential advances to improve its success rate. Atosiban, a combined oxytocin/vasopressin V1a receptor antagonist, is a novel class of drug involved in basic priming of the uterus for successful implantation during embryo t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Vineet, Agarwal, Himani, Goel, Sugandha, Roy, Priyankur, Choudhary, Sumesh, Lamba, Sunita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094537/
https://www.ncbi.nlm.nih.gov/pubmed/30158812
http://dx.doi.org/10.4103/jhrs.JHRS_7_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094537/
https://www.ncbi.nlm.nih.gov/pubmed/30158812
http://dx.doi.org/10.4103/jhrs.JHRS_7_17

Ejemplares similares